BridgeBio Pharma (BBIO) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

BridgeBio Pharma (BBIO) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 23, 2024 (03:28)

Sector: Healthcare

The share price of BridgeBio Pharma, Inc. (BBIO) now

Latest session on the 22nd of July for
BridgeBio Pharma, Inc. is positive
Trading Volume: 1236456
Open: 26.54 /  High: 26.85 /  Low: 25.882
What analysts predict: $49.75
52-week High/Low: $44.32 / $21.62

50/200 Day Moving Average: $27.29 / $30.52

This figure corresponds to the Average Price over the previous 50/200 days. For BridgeBio Pharma stocks, the 50-day moving average is the resistance level today.

For BridgeBio Pharma stocks, the 200-day moving average is the resistance level today.

Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one BridgeBio Pharma share be worth in 2024 - 2028?

When should I take profit in BridgeBio Pharma stock? When should I record a loss on BridgeBio Pharma stock? What are analysts' forecasts for BridgeBio Pharma stock? What is the future of BridgeBio Pharma stock? We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BridgeBio Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BridgeBio Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BridgeBio Pharma shares. This happens once a day.


Historical and forecast chart of BridgeBio Pharma stock

The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BridgeBio Pharma stock price can be found in the table below.

Long-term forecasts by years.

BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.

BridgeBio Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 25 26.67 26.31 27.04 2.80
Jul 26 26.74 26.28 27.33 4.00
Jul 27 27.10 26.59 27.64 3.94
Jul 28 26.74 26.54 26.91 1.39
Jul 29 26.37 26.06 26.63 2.19
Jul 30 27.05 26.78 27.49 2.67
Jul 31 27.31 26.94 27.74 2.98
Aug 01 27.27 26.92 27.61 2.55
Aug 02 26.83 26.57 27.26 2.58
Aug 03 26.64 26.32 26.94 2.37
Aug 04 26.18 25.99 26.55 2.14
Aug 05 26.57 26.20 27.15 3.62
Aug 06 26.45 26.15 27.04 3.37
Aug 07 27.06 26.65 27.31 2.47
Aug 08 27.04 26.69 27.49 3.01
Aug 09 26.89 26.60 27.05 1.70
Aug 10 27.01 26.40 27.58 4.45
Aug 11 27.79 27.20 28.26 3.89
Aug 12 26.97 26.50 27.50 3.76
Aug 13 26.21 25.70 26.81 4.31
Aug 14 26.19 25.83 26.49 2.55
Aug 15 25.96 25.68 26.27 2.30
Aug 16 26.39 25.94 26.70 2.93
Aug 17 26.51 26.13 26.99 3.29
Aug 18 26.35 25.82 26.53 2.72
Aug 19 26.04 25.87 26.34 1.84
Aug 20 26.26 25.76 26.72 3.73
Aug 21 26.51 26.10 26.89 3.05
Aug 22 25.88 25.49 26.32 3.23
Aug 23 26.00 25.49 26.26 3.03

BridgeBio Pharma Daily Price Targets


BridgeBio Pharma Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $26.67.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.722%.
Pessimistic target level: 26.31
Optimistic target level: 27.04

BridgeBio Pharma Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $26.74.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.846%.
Pessimistic target level: 26.28
Optimistic target level: 27.33

BridgeBio Pharma Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $27.10.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.795%.
Pessimistic target level: 26.59
Optimistic target level: 27.64

BridgeBio Pharma Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $26.74.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 1.371%.
Pessimistic target level: 26.54
Optimistic target level: 26.91

BridgeBio Pharma Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $26.37.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.139%.
Pessimistic target level: 26.06
Optimistic target level: 26.63

BridgeBio Pharma Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $27.05.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.598%.
Pessimistic target level: 26.78
Optimistic target level: 27.49

BBIO (BBIO) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 25.58 23.85 27.84 14.33
Sep. 27.77 25.86 29.36 11.93
Oct. 26.58 23.99 28.96 17.18
Nov. 23.99 23.37 24.83 5.90
Dec. 24.27 22.34 25.18 11.27

BridgeBio Pharma forecast for this year


BridgeBio Pharma Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $25.5772. Pessimistic: $23.85. Optimistic: $27.84


BridgeBio Pharma Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $27.7717. Pessimistic: $25.86. Optimistic: $29.36


BridgeBio Pharma Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $26.5803. Pessimistic: $23.99. Optimistic: $28.96


BridgeBio Pharma Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $23.9887. Pessimistic: $23.37. Optimistic: $24.83


BridgeBio Pharma Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $24.2694. Pessimistic: $22.34. Optimistic: $25.18



BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 25.44 23.45 26.66 12.03
Feb 25.34 23.33 27.05 13.76
Mar 26.39 25.19 27.46 8.25
Apr 26.12 23.81 26.86 11.37
May 23.27 21.51 24.84 13.39
Jun 21.60 20.39 23.37 12.74
Jul 20.70 19.12 21.67 11.80
Aug 20.76 19.41 22.05 11.99
Sep 19.84 19.25 21.77 11.61
Oct 20.59 19.22 21.58 10.92
Nov 22.89 21.79 24.50 11.05
Dec 21.82 20.77 23.46 11.48

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 21.68 20.72 23.03 10.03
Feb 23.82 22.02 24.72 10.90
Mar 21.84 20.30 23.34 13.01
Apr 20.64 19.11 22.63 15.54
May 20.72 18.89 21.91 13.77
Jun 21.13 19.45 22.01 11.61
Jul 20.96 20.20 21.89 7.72
Aug 19.74 18.61 20.56 9.49
Sep 18.84 18.18 20.04 9.29
Oct 20.48 19.81 21.84 9.27
Nov 18.43 17.35 19.99 13.19
Dec 16.82 15.75 18.14 13.14

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 15.16 13.98 15.60 10.36
Feb 14.24 13.79 15.68 12.04
Mar 14.42 13.37 15.75 15.11
Apr 16.22 15.48 17.32 10.59
May 15.61 14.96 16.79 10.88
Jun 17.33 15.94 18.84 15.43
Jul 18.06 17.59 19.23 8.54
Aug 16.93 15.28 18.18 15.98
Sep 16.00 15.48 16.79 7.80
Oct 17.19 16.27 18.84 13.64
Nov 17.97 17.51 18.58 5.78
Dec 16.29 15.04 16.78 10.35

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 15.93 14.92 17.11 12.83
Feb 15.39 13.99 16.71 16.28
Mar 14.63 13.53 15.73 14.02
Apr 14.48 13.14 15.67 16.10
May 14.59 13.64 15.50 11.99
Jun 13.80 12.47 15.23 18.13
Jul 15.03 14.51 15.60 7.02
Aug 15.58 14.16 17.04 16.88
Sep 15.66 14.64 16.66 12.10
Oct 16.11 15.69 17.03 7.87
Nov 15.77 15.04 16.84 10.72
Dec 15.57 14.52 16.40 11.48

BridgeBio Pharma information and performance

BridgeBio Pharma Address

421 KIPLING STREET, PALO ALTO, CA, US

Market Capitalization: 4 900 909 000 $

Market capitalization of the BridgeBio Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BBIO shares in the company outstanding by the market price of one share.

EBITDA: -466 449 984 $

EBITDA of BridgeBio Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.23

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 114.62
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 672.24

Enterprise Value (EV) /Revenue

EV To EBITDA: -11.06

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 187129000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.